1228 related articles for article (PubMed ID: 8877711)
1. Detection of minimal disease in patients with solid tumors.
Pantel K
J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
[TBL] [Abstract][Full Text] [Related]
2. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods.
Lambrechts AC; van 't Veer LJ; Rodenhuis S
Ann Oncol; 1998 Dec; 9(12):1269-76. PubMed ID: 9932154
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterisation of minimal residual disease in solid tumors.
Pantel K; Otte M
Acta Med Austriaca Suppl; 2000; 52():8-12. PubMed ID: 11261279
[TBL] [Abstract][Full Text] [Related]
4. [Micrometastases in pediatric oncology].
Bernard F; Aerts I; Margueritte G; Astruc J
Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
Ghossein RA; Carusone L; Bhattacharya S
In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumours: a review.
Pantel K; Ahr A
Nucl Med Commun; 1998 Jun; 19(6):521-7. PubMed ID: 10234655
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis of head and neck cancer.
van Houten VM; van den Brekel MW; Denkers F; Colnot DR; Westerga J; van Diest PJ; Snow GB; Brakenhoff RH
Recent Results Cancer Res; 2000; 157():90-106. PubMed ID: 10857164
[TBL] [Abstract][Full Text] [Related]
8. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of minimal residual disease in bone marrow and blood in cancer patients--methods and clinical implications.
Kvalheim G
Acta Oncol; 1998; 37(5):455-62. PubMed ID: 9831374
[TBL] [Abstract][Full Text] [Related]
10. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of micrometastatic bone marrow involvement.
Braun S; Pantel K
Breast Cancer Res Treat; 1998; 52(1-3):201-16. PubMed ID: 10066083
[TBL] [Abstract][Full Text] [Related]
12. [Molecular detection of minimal residual disease in melanoma and solid tumors].
Vázquez V; Otero LL; Laurent VE; Gabri MR; Gómez DE; Alonso DF
Medicina (B Aires); 2009; 69(1 Pt 2):181-90. PubMed ID: 19414304
[TBL] [Abstract][Full Text] [Related]
13. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
14. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
15. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview.
Zippelius A; Pantel K
Ann N Y Acad Sci; 2000 Apr; 906():110-23. PubMed ID: 10818606
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.
Ghossein RA; Rosai J
Cancer; 1996 Jul; 78(1):10-6. PubMed ID: 8646704
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
[TBL] [Abstract][Full Text] [Related]
18. Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR.
Weber T; Lacroix J; Wörner S; Weckauf H; Winkler S; Hinz U; Schilling T; Frank-Raue K; Klar E; Knebel Doeberitz Mv Mv
Int J Cancer; 2003 Jan; 103(1):126-31. PubMed ID: 12455065
[TBL] [Abstract][Full Text] [Related]
19. [Molecular diagnostics of malignant melanoma: molecular staging, minimal residual disease].
Tímár J; Csuka O
Magy Onkol; 2003; 47(1):63-6. PubMed ID: 12704457
[TBL] [Abstract][Full Text] [Related]
20. Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
Köstler WJ; Brodowicz T; Hejna M; Wiltschke C; Zielinski CC
Cancer Detect Prev; 2000; 24(4):376-403. PubMed ID: 11059569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
